Volume 32, Number 6—June 2026
Research
Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022–2024
Table 4
Summary of antimicrobial-resistant Neisseria gonorrhoeae cluster groups, New South Wales, Australia, 2022–2024*
| Cluster ID | Size | MLST | penA allele type | X23 rRNA | Sex at birth, no. (%) |
Sexual risk exposure group, no. (%) |
Place of acquisition, no. (%) | SW or client or SOPV, no. (%) |
Median no. contacts (range) |
|---|---|---|---|---|---|---|---|---|---|
| 22AZ-1 |
2 |
9363 |
2.001 |
A2059G |
2 M (100.0) |
2 MSM (100.0) |
2 OS (100.0) |
0 |
Unknown |
| 23AZ-1 |
2 |
11200 |
2.001 |
A2059G |
2 M (100.0) |
2 MSM (100.0) |
2 local (100.0) |
0 |
2.5 (1–4) |
| 24AZ-1 |
13 |
11200 |
2.001 |
A2059G |
13 M (100.0) |
12 MSM (92.3), 1 BI (7.7) |
13 local (100.0) |
2 (15.4) |
3.5 (1–30) |
| 24AZ-2 |
4 |
11200 |
2.001 |
A2059G |
4 M (100.0) |
3 MSM (75.0), 1 BI (25.0) |
3 local (75.0), 2 OS (25.0) |
1 (25.0) |
9.0 (1–15) |
| 22CRO-1 |
13 |
7827 |
13.001 |
NA |
5 F (38.5), 8 M (61.5) |
12 HET (92.3), 1 MSM (7.7) |
13 local (100.0) |
5 (38.5) |
1.0 (1–5) |
| 22CRO-2 |
2 |
15331 |
18.001 |
NA |
2 M (100.0) |
2 MSM (100.0) |
2 local (100.0) |
0 |
3.0† |
| 23CRO-3 |
2 |
15331 |
18.001 |
NA |
2 M (100.0) |
2 MSM (100.0) |
2 local (100.0) |
0 |
6.0† |
| 24CRO-1 |
5 |
1901 |
60.001 |
NA |
2 F (40.0), 3 M (60.0) |
5 HET (100.0) |
5 local (100.0) |
2 (40.0) |
1.0 (1–2) |
| 24CRO-2 | 3 | 9903 | 60.001 | NA | 3 M (100.0) | 3 MSM (100.0) | 2 local (66.6) | 0 | 1.5 (1–2) |
| 1 OS (33.3 |
|||||||||
| Total | 46 | NA | NA | NA | 7 F (15.2) | 17 HET (37.0) | 42 local (91.3) | 10 (22.7) | 2.0 (1–30) |
| 39 M (84.8) | 27 MSM (58.7), 2 BI (4.3) | 4 OS (8.7) |
*BI, bisexual; HET, heterosexual; ID, identification; local, Australia acquisition; MLST, multilocus sequence type; MSM, men who have sex with men; NA, not applicable; OS, overseas acquisition; SOPV, sex on premises venue; SW, sex worker. †Median number of contacts (based on 1 available value).
1These first authors contributed equally to this article.
2These joint senior authors contributed equally to this article.
Page created: April 30, 2026
Page updated: June 01, 2026
Page reviewed: June 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.